Related Experiment Video
Updated: Oct 18, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Clinical Outcome and Antibiotic Dosing Differences by Weight in Children With Acute Osteomyelitis
Kathryn E Kyler1,2, Brian R Lee3, Earl F Glynn3
1Children's Mercy Kansas City, Kansas City, Missouri kekyler@cmh.edu.
Insights
Children with overweight and obesity hospitalized for acute hematogenous osteomyelitis (AHO) had higher procedure rates and longer hospital stays. They also received lower weight-based antibiotic doses, indicating weight should guide AHO treatment.
Area of Science:
- Pediatric infectious diseases
- Clinical outcomes research
- Antibiotic dosing optimization
Background:
- Acute hematogenous osteomyelitis (AHO) is a bone infection in children.
- Weight status may influence clinical outcomes and treatment of AHO.
- Current antibiotic dosing practices may not adequately account for weight variations.
Purpose of the Study:
- To investigate weight-based differences in clinical outcomes for pediatric AHO.
- To assess antibiotic dosing variability among children with AHO across different weight categories.
Main Methods:
- Retrospective cohort study of 755 children (2-17 years) with AHO (2010-2017).
- Weight categories: healthy, overweight, obesity based on CDC BMI percentiles.
- Comparison of procedure rates, complications, length of stay (LOS), and initial weight-adjusted antibiotic doses.
Main Results:
- Overweight and obese children had higher rates of surgical procedures (19%, 17%) vs. healthy weight (10%).
- Longer LOS observed in overweight (5.7 days) and obese (5.8 days) children compared to healthy weight (4.9 days).
- Higher weight categories received lower mean weight-adjusted daily antibiotic doses.
Conclusions:
- Children with overweight/obesity and AHO face increased procedures and longer LOS.
- Weight-based antibiotic dosing was lower in higher weight categories.
- Clinical management of pediatric AHO should incorporate patient weight considerations.
Objectives:
To evaluate for weight-based differences in clinical outcomes and antibiotic dosing variability for children hospitalized with acute hematogenous osteomyelitis (AHO).
Methods:
We performed a retrospective cohort study of children aged 2 to 17 years and hospitalized with a primary AHO International Classification of Diseases, Ninth Revision or International Classification of Diseases, 10th Revision diagnosis code between 2010 and 2017 using the Cerner Health Facts database. Weight categories (healthy, overweight, obesity) were determined by using Centers for Disease Control and Prevention age- and sex-specific BMI percentiles. Rates of procedures, complications, and length of stay (LOS) were compared between groups. Dosing variability between groups was assessed by comparing the initial milligrams per kilogram per day of prescribed antibiotics.
Results:
We identified 755 children with AHO for inclusion. Children with overweight and obesity were more likely to undergo surgical procedures (19% and 17%, respectively) compared with children with a healthy weight (10%; P = .009). They also had a longer LOS (5.7 and 5.8 days) than children with a healthy weight (4.9 days; P = .03). There were no differences in complication rates between weight categories. Mean weight-adjusted daily dose for the most frequently prescribed antibiotics was different by weight category, with children in higher weight categories more likely to receive lower weight-based doses.
Conclusions:
Children with overweight and obesity hospitalized for AHO were more likely to undergo procedures, have longer LOS, and receive lower weight-based antibiotic dosing compared with children with a healthy weight. Our findings suggest that weight should be carefully considered when treating children with AHO.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Drug Dosing: Obese Patients
Tonsillitis II: Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

